| ACRS YTD Return Table | ||||||||||||||||||||||||||||||
ACRS YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Compare ACRS YTD return (see YTD Return Formula;
YTD Return vs Yield) versus benchmarks: YTD Return on S&P YTD Return on Dow YTD Return on Nasdaq 100 YTD Return on Russell 2000 YTD Return on Gold YTD Return on 10 Year Treasury |
| ACRS Share Performance |
| ACRS YTD Return Chart | |||
| |||
| About Aclaris Therapeutics Inc |
| Aclaris Therapeutics is a physician-led biopharmaceutical company focused on dermatological and immuno-inflammatory diseases. Co.'s commercial product, ESKATA (hydrogen peroxide) topical solution, 40% (w/w), or ESKATA, is a proprietary formulation of high-concentration hydrogen peroxide topical solution for raised seborrheic keratosis, a common non-malignant skin tumor. Co. has acquired RHOFADE (oxymetazoline hydrochloride) cream, 1%, or RHOFADE, which includes a license to certain intellectual property for RHOFADE, from Allergan Sales, LLC. RHOFADE has been approved for the topical treatment of persistent facial erythema (redness) associated with rosacea in adults. The ACRS YTD return is shown above.
The YTD Return on the ACRS YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether ACRS YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ACRS YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| ACRS Current Stock Quote |
Get Free SEC filing alerts for ACRS:
ACRS SEC Filing Email Alerts Service 
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Aclaris Therapeutics (ACRS) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
ACRX YTD Return |
Video: Don't Forget Dividends in YTD Return!